Induced sputum and occupational diseases other than asthma

Current Opinion in Allergy and Clinical Immunology

Volumn 9, Issue 2, 2009, Pages 93-96

  Fireman, Elizabeth ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Induced sputum; Monitoring; Occupational exposure

Indexed keywords

ALUMINUM; ASBESTOS FIBER; BERYLLIUM; CYTOKINE; GELATINASE B; GOLD; MERCURY; SILICON DIOXIDE; SILVER; TIN; ZINC; BIOLOGICAL MARKER;

AIRWAY; ASBESTOSIS; BERYLLIOSIS; CYTOKINE PRODUCTION; DISASTER; DUST; ENZYME ANALYSIS; FIRE FIGHTER; FORCED EXPIRATORY VOLUME; HEALTH HAZARD; HUMAN; INDUCED SPUTUM; INFLAMMATION; LEUKOCYTE DIFFERENTIAL COUNT; LUNG BIOPSY; LUNG DISEASE; LUNG FUNCTION; LUNG LAVAGE; MONITORING; NON INVASIVE PROCEDURE; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL LUNG DISEASE; OCCUPATIONAL MEDICINE; PARTICLE SIZE; PARTICULATE MATTER; PRIORITY JOURNAL; REVIEW; SCANNING ELECTRON MICROSCOPY; SPUTUM ANALYSIS; T LYMPHOCYTE SUBPOPULATION; WORKPLACE; ANIMAL; BIOPSY; CHEMISTRY; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; IMMUNOLOGY; LUNG GRANULOMA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RESPIRATORY TRACT EXAMINATION; SECRETION; SPUTUM;

ANIMALS; BERYLLIOSIS; BIOLOGICAL MARKERS; BIOPSY; BRONCHOALVEOLAR LAVAGE; CHRONIC DISEASE; CYTOKINES; DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; GRANULOMA, RESPIRATORY TRACT; HUMANS; LUNG DISEASES, OBSTRUCTIVE; OCCUPATIONAL DISEASES; PARTICULATE MATTER; SPUTUM; T-LYMPHOCYTE SUBSETS;

EID: 65549095846     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32832921e0     Document Type: Review

References (28)

1. Cordeiro CR, Jones JC, Alfaro T, Ferreira AJ. Bronchoalveolar lavage in occupational lung diseases. Semin Respir Crit Care Med 2007; 28:504- 513. This is the most recent insightful review dealing with BAL and occupational lung diseases.
2. Paoletti L. Mineral particles in bronchoalveolar lavage fluid (BALF): an attempt at designing a quantitative model. Arch Environ Health 1997; 52:384-389.
3. Mutsaers SE, Harrison NK, McAnulty RJ, et al. Fibroblast mitogens in bronchoalveolar lavage (BAL) fluid from asbestos-exposed subjects with and without clinical evidence of asbestosis: no evidence for the role of PDGF, TNF-alpha, IGF-1, or IL-1 beta. J Pathol 1998; 185:199-203.
4. Zacharasiewicz A. Fractional exhaled nitric oxide and induced sputum. Paediatr Respir Rev 2007; 8:94-96. This is an excellent review that shows that FeNO and induced sputum should be seen as complementary to the conventional tools, such as spirometry and bronchial hyperresponsiveness (BHR) testing.
5. Koutsokera A, Loukides S, Gourgoulianis KI, Kostikas K. Biomarkers in the exhaled breath condensate of healthy adults: mapping the path towards reference values. Curr Med Chem 2008; 15:620-630. This review focuses mainly on the presentation of normal values of the most widely studied EBC markers.
6. Balbi B, Pignatti P, Corradi M, et al. Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults. Eur Respir J 2007; 30:769-781. This review reports reference values from healthy individuals for use in the new, noninvasive methodologies.
7. Lemiere C. Induced sputum and exhaled nitric oxide as noninvasive markers of airway inflammation from work exposures. Curr Opin Allergy Clin Immunol 2007; 7:133-137. The use of induced sputum as an additional tool in the investigation of occupational asthma is supported by this study. The authors recommend that the role of exhaled nitric oxide in the investigation of occupational asthma be clarified due to conflicting evidence reported in the literature.
8. Fireman E, Greif J, Bologovov E, et al. Evaluation of occupational lung diseases by induced sputum compared to bronchoalveolar lavage. Chest 1999; 11:1720-1728.
9. Lerman Y, Segal B, Rochvarger M, et al. Induced-sputum particle size distribution and pulmonary function in foundry workers. Arch Environ Health 2003; 58:565-571.
10. Marek W, Kotschy-Lang N, Muti A, et al. Can semi-automated image cytometry on induced sputum become a screening tool for lung cancer? Evaluation of quantitative semi-automated sputum cytometry on radon- and uraniumexposed workers. Eur Respir J 2001; 18:942-950.
11. Fireman E, Lerman Y, Stark M, et al. Detection of occult lung impairment in welders by induced sputum particles and breath oxidation. Am J Ind Med 2008; 51:503-511. This is the first study to show that the induced sputum particle content is timedependent and, in this context, this parameter could be used for biological monitoring.
12. Rosenberg G, Harrison R. Biological monitoring. In: La Dou J, editor. Occupational and environmental medicine, 2nd ed. New York: Appleton and Lange; 1997. pp. 637-646.
13. Fireman EM, Lerman Y, Ben Mahor M, et al. Redefining idiopathic interstitial lung disease into occupational lung diseases by analysis of chemical composition of inhaled dust particles in induced sputum and/or lung biopsy specimens. Toxicol Ind Health 2007; 23:607-615. This is the first study that compared the mineral content particles in induced sputum to tissue analysis in workers exposed to silica and hard metal diseases.
14. Teschler H, Thompson AB, Dollenkamp R, et al. Relevance of asbestos bodies in sputum. Eur Respir J 1996; 9:680-686.
15. Capellaro E, Chiesa A, Villari S, et al. Asbestos bodies in bronchoalveolar lavage fluid and sputum. Med Lav 1997; 88:99-107.
16. Setta JH, Neder JA, Bagatin E, et al. Relationship between induced sputum cytology and inflammatory status with lung structural and functional abnormalities in asbestosis. Am J Ind Med 2008; 51:186-194. These authors employed induced sputum to show correlations between HRCT abnormalities with inflammatory cytokines and PFT impairment.
17. Lerman Y, Schwarz Y, Kaufman G, et al. Case series: use of induced sputum in the evaluation of occupational lung diseases. Arch Environ Health 2003; 58:284-289.
18. Guber A, Lerman S, Lerman Y, et al. Pulmonary fibrosis in a patient with exposure to glass wool fibers. Am J Ind Med 2006; 49:1066-1069.
19. Fireman EM, Lerman Y, Ganor E, et al. Induced sputum assessment in New York City firefighters exposed to World Trade Center dust. Environ Health Perspect 2004; 112:1564-1569.
20. Szeinuk J, Padilla M, de la Hoz RE. Potential for diffuse parenchymal lung disease after exposures at World Trade Center disaster site. Mt Sinai J Med 2008; 75:101-107. This is a follow-up study on the presence of parenchymal lung diseases among individuals exposed to WTC dust.
21. Fireman E, Topilsky I, Greif J, et al. Evaluation of interstitial lung diseases by induced sputum compared to bronchoalveolar lavage. Respir Med 1999; 93:827-828.
22. Moodley YP, Dorasamy T, Venketasamy S, et al. Correlation of CD4/CD8 ratio and TNF a levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis. Thorax 2000; 55:696-699.
23. Fireman E, Haimsky E, Noiderfer M, et al. Misdiagnosis of sarcoidosis in patients with chronic beryllium disease. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20:144-148.
24. Mü ller-Quernheim J, Gaede KI, Fireman E, Zissel G. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 2006; 27:1190-1195.
25. Cataldo DD, Bettiol J, Noel A, et al. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 2002; 122: 1553-1559.
26. Li Q, Park PW, Wilson CL, Parks WC. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 2002; 111:635-646.
27. Lerman Y, Moscovich A, Fireman E. Unexpected smoking-linked high MMP-9 in induced sputum of hazardous dust-exposed workers. Mediators Inflamm 2006; 2006:24827.
28. Prince P, Boulay ME, Page' N, et al. Induced sputum markers of fibrosis and decline in pulmonary function in asbestosis and silicosis: a pilot study. Int J Tuberc Lung Dis 2008; 12:813-819.